From January 1, 2023 to March 31, 2023, the company has repurchased 5,200,000 shares, representing 7.97% for $55.1 million. With this, the company has completed the repurchase of 17,939,115 shares, representing 25.19% for $183.26 million under the buyback announced on September 19, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.89 USD | +5.32% | +4.32% | -11.92% |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
May. 13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.92% | 456M | |
+31.37% | 588B | |
-2.78% | 364B | |
+20.52% | 326B | |
+5.60% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.21% | 167B | |
+0.17% | 161B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.